Fifth Third Bancorp
TEVA icon

Fifth Third Bancorp’s Teva Pharmaceuticals TEVA Stock Holding History

Fifth Third Bancorp’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Sell
30,636
-232
-0.8% -$7.73K ﹤0.01% 1659
2026
Q1 		$930K Sell
30,868
-932
-3% -$30K ﹤0.01% 1681
2025
Q4 		$992K Buy
31,800
+2,155
+7% +$53.1K ﹤0.01% 618
2025
Q3 		$599K Sell
29,645
-3,160
-10% -$55.5K ﹤0.01% 747
2025
Q2 		$550K Buy
32,805
+10,820
+49% +$175K ﹤0.01% 737
2025
Q1 		$338K Buy
21,985
+3,265
+17% +$58.3K ﹤0.01% 840
2024
Q4 		$413K Buy
18,720
+18,444
+6,683% +$336K ﹤0.01% 799
2024
Q3 		$4.97K Hold
276
– – ﹤0.01% 2187
2024
Q2 		$4.49K Buy
276
+51
+23% +$786 ﹤0.01% 2146
2024
Q1 		$3.17K Hold
225
– – ﹤0.01% 2160
2023
Q4 		$2.35K Sell
225
-71
-24% -$663 ﹤0.01% 2327
2023
Q3 		$3.02K Sell
296
-132
-31% -$1.23K ﹤0.01% 2301
2023
Q2 		$3.22K Sell
428
-58
-12% -$470 ﹤0.01% 2320
2023
Q1 		$4.3K Buy
486
+402
+479% +$3.98K ﹤0.01% 2384
2022
Q4 		$766 Sell
84
-1,019
-92% -$8.89K ﹤0.01% 2567
2022
Q3 		$9K Buy
1,103
+58
+6% +$513 ﹤0.01% 1997
2022
Q2 		$8K Sell
1,045
-80
-7% -$697 ﹤0.01% 2096
2022
Q1 		$11K Buy
1,125
+80
+8% +$668 ﹤0.01% 2035
2021
Q4 		$8K Sell
1,045
-545
-34% -$4.92K ﹤0.01% 2191
2021
Q3 		$15K Sell
1,590
-55,755
-97% -$522K ﹤0.01% 1885
2021
Q2 		$568K Buy
57,345
+2,492
+5% +$26.4K ﹤0.01% 666
2021
Q1 		$633K Buy
54,853
+28,000
+104% +$321K ﹤0.01% 637
2020
Q4 		$259K Buy
26,853
+1,045
+4% +$10K ﹤0.01% 838
2020
Q3 		$233K Hold
25,808
– – ﹤0.01% 819
2020
Q2 		$318K Hold
25,808
– – ﹤0.01% 733
2020
Q1 		$232K Hold
25,808
– – ﹤0.01% 783
2019
Q4 		$253K Buy
25,808
+14,650
+131% +$131K ﹤0.01% 869
2019
Q3 		$77K Sell
11,158
-3,050
-21% -$23.4K ﹤0.01% 1218
2019
Q2 		$131K Buy
14,208
+4,770
+51% +$57.5K ﹤0.01% 1049
2019
Q1 		$148K Buy
9,438
+2,732
+41% +$48.2K ﹤0.01% 950
2018
Q4 		$103K Sell
6,706
-935
-12% -$19.2K ﹤0.01% 1031
2018
Q3 		$165K Sell
7,641
-7,305
-49% -$170K ﹤0.01% 954
2018
Q2 		$363K Buy
14,946
+1,658
+12% +$33.8K ﹤0.01% 754
2018
Q1 		$227K Sell
13,288
-6,293
-32% -$123K ﹤0.01% 857
2017
Q4 		$371K Sell
19,581
-10,238
-34% -$154K ﹤0.01% 732
2017
Q3 		$525K Sell
29,819
-6,650
-18% -$150K ﹤0.01% 647
2017
Q2 		$1.21M Sell
36,469
-13,577
-27% -$420K 0.01% 493
2017
Q1 		$1.61M Buy
50,046
+528
+1% +$18K 0.01% 440
2016
Q4 		$1.79M Sell
49,518
-33,976
-41% -$1.36M 0.01% 428
2016
Q3 		$3.84M Sell
83,494
-7,868
-9% -$411K 0.03% 316
2016
Q2 		$4.59M Sell
91,362
-3,101
-3% -$165K 0.04% 287
2016
Q1 		$5.05M Buy
94,463
+4,904
+5% +$288K 0.04% 279
2015
Q4 		$5.88M Buy
89,559
+11,597
+15% +$717K 0.05% 253
2015
Q3 		$4.4M Sell
77,962
-3,543
-4% -$230K 0.04% 289
2015
Q2 		$4.82M Sell
81,505
-2,329
-3% -$144K 0.04% 281
2015
Q1 		$5.22M Buy
83,834
+1,995
+2% +$116K 0.05% 278
2014
Q4 		$4.71M Buy
81,839
+4,887
+6% +$272K 0.04% 302
2014
Q3 		$4.14M Sell
76,952
-2,884
-4% -$153K 0.04% 313
2014
Q2 		$4.18M Sell
79,836
-12
-0% -$613 0.04% 317
2014
Q1 		$4.22M Sell
79,848
-5,349
-6% -$247K 0.04% 318
2013
Q4 		$3.42M Sell
85,197
-57,353
-40% -$2.26M 0.03% 350
2013
Q3 		$5.39M Sell
142,550
-3,878
-3% -$151K 0.06% 280
2013
Q2 		$5.74M Buy
+146,428
New +$5.7M 0.06% 260

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Fifth Third Bancorp's TEVA Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Teva Pharmaceuticals (TEVA) stake by 0.75% in Q2 2026, selling an estimated $7.73K and leaving 30,636 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1659.

Fifth Third Bancorp first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.88M in Q4 2015. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Fifth Third Bancorp held 30,636 shares of Teva Pharmaceuticals worth $1.04M as of Q2 2026.
  • Fifth Third Bancorp sold 232 Teva Pharmaceuticals shares in Q2 2026, an estimated $7.73K.
  • Teva Pharmaceuticals made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #1659 holding.
  • Fifth Third Bancorp first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Fifth Third Bancorp's Teva Pharmaceuticals position peaked at $5.88M in Q4 2015.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.